NATROX® Wound Care is an Inotec AMD brand. The specialist wound care company based in Cambridge, England was formed specifically to introduce new technologies to healthcare professionals around the world to promote faster and better healing to patients.
The company’s flagship product, NATROX®?O2 topical oxygen wound therapy, is positioned to become an integral part of global wound care treatment regimes. It was designed by the company’s founder to help his aging aunt who was long suffering from a painful non-healing venous leg ulcer. After much research, he learned oxygen was the secret to healing. He quickly set out to develop a product that could deliver oxygen to a wound without harmful chemicals or adding pressure to the frail skin surrounding the wound. The technology known as NATROX®?O2 was soon born.
In an effort to share this solution with others, NATROX® Wound Care was founded with a mission to transform the quality of life for anyone living with a chronic wound. Because, surely, there were others struggling to close a hard-to-heal wound. The company believes everyone deserves the chance to heal.
What is NATROX® O2 Continuous Topical Oxygen Therapy
This small, wearable medical device uses the natural properties of oxygen to stimulate healing in previously non-healing wounds. It is non-invasive, comfortable, portable, and highly effective.
Ideal across all clinical and home care settings. It can be used during any phase of healing and works with nearly all standard secondary dressings. Lightweight and discreet, NATROX® O2 gives patients complete freedom of movement.
Benefits of using NATROX® O2 Continuous Topical Oxygen Therapy
- 71% greater healing rate¹
- 76% experienced fast, substantial pain relief²
- 69% stopped taking opioids²
- 90% patient satisfaction³
- 85% of patients remained healed after 1 year4
Types of wounds to consider include:
- Diabetic foot ulcers (DUFs)
- Leg ulcers (venoud, arertial, mixed)
- Pressure injuries
- Non-healing surgical wounds
- Any wound that fails to respond to standard of care
REFERENCES:
- Serena TE, Bullock NM, Cole W, et al. (2021) Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled trial. J Wound Care,
30(Sup5):s7-14
- Jebril W, Nowak M, Palin L, et al. (2022) Topical oxygen treatment relieves pain from hard-to-heal leg ulcers and improves healing: a case series. J Wound
Care, 31(1):4-11.
- Jones N, Curran G, Ivins M, et al. (2017) The role of topical oxygen therapy in the treatment of diabetic foot ulceration. [Poster presentation] 2017 Wounds UK:
Harrogate.
Al-Jalodi O, Kupcella M, Breisinger K, et al. (2022) A multicenter clinical trial evaluating the durability of diabetic foot ulcer healing in ulcers treated with topical oxygen and standard of care versus standard of care alone 1 year post healing. Int Wound J, 19(7):1-5
This small, wearable medical device uses the natural properties of oxygen to stimulate healing in previously non-healing wounds. It is non-invasive, comfortable, portable, and highly effective. Ideal across all clinical and home care settings. It can be used during any phase of healing and works with nearly all standard secondary dressings. Lightweight and discreet, NATROX® O2 gives patients complete freedom of movement.
